comparemela.com
Home
Live Updates
Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer : comparemela.com
Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
BETHESDA, Md., April 12, 2023 -- Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced the appointment of... | June 19, 2023
Related Keywords
Evan Ballantyne ,
Matthias Alder ,
C Evan Ballantyne ,
Salvatore Calabrese ,
Michaelj Fox Foundation For Parkinson Research ,
Health Science ,
Gain Therapeutics Inc ,
Orchestra Biomed Inc ,
Silverstein Foundation For Parkinson ,
Exchange Commission On ,
Nasdaq ,
Synthetic Biologics Inc ,
Cerecin Inc ,
Clinical Data Inc ,
Exchange Commission ,
Company Annual Report On Form ,
University Of Western Ontario ,
University Of Windsor ,
European Union Horizon ,
Oncxerna Therapeutics Inc ,
Agenus Inc ,
Chief Financial Officer ,
Chief Financial ,
Chief Executive Officer ,
Oncxerna Therapeutics ,
Orchestra Biomed ,
Executive Vice President ,
Clinical Data ,
Forest Laboratories ,
Synthetic Biologics ,
Western Ontario ,
Equity Incentive Plan ,
Transition Date ,
Inducement Awards ,
Inducement Plan ,
Nasdaq Listing ,
Gain Therapeutics ,
Silverstein Foundation ,
Private Securities Litigation Reform Act ,
Annual Report ,
Media Contact ,
comparemela.com © 2020. All Rights Reserved.